Eli Lilly’s diabetes drug tirzepatide gets approval in China

ELI Lilly said on Tuesday (May 21) its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying ...

Lilly’s US$2.5 billion German plant will boost obesity-drug supply

by Brand Post

April 8, 2024

0

ELI Lilly kicked off construction of a new plant to boost the production of its wildly popular weight-loss drugs, which ...

Lilly’s climb has analysts asking US$1 trillion question

by Brand Post

February 18, 2024

0

ELI Lilly & Co’s relentless stock records have Morgan Stanley analysts musing whether it will become the first US company ...

Eli Lilly’s Experimental Alzheimer’s Drug Slows Cognitive Decline by 35%

by Brand Post

May 4, 2023

0

US pharma giant Eli Lilly's experimental Alzheimer's drug slowed clinical decline by 35 per cent compared to placebo, and resulted ...

FDA Pauses Authorization For Eli Lilly’s COVID Antibody Treatment

by Brand Post

December 1, 2022

0

The Food and Drug Administration on Wednesday paused the authorization of Eli Lilly and Co.'s bebtelovimab drug, stating that it ...

Tag: Lillys